234 related articles for article (PubMed ID: 20946923)
1. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
2. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
[TBL] [Abstract][Full Text] [Related]
3. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors.
Ali HS; York P; Blagden N
Int J Pharm; 2009 Jun; 375(1-2):107-13. PubMed ID: 19481696
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
Verma S; Gokhale R; Burgess DJ
Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
[TBL] [Abstract][Full Text] [Related]
5. A stable hydrocortisone nanosuspension for improved dissolution: Preparation, characterization and in vitro evaluation.
Ali HS; Khan S; York P; Shah SM; Khan J; Hussain Z; Khan BA
Pak J Pharm Sci; 2017 Sep; 30(5):1635-1643. PubMed ID: 29084684
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
[TBL] [Abstract][Full Text] [Related]
7. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
8. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS).
Friedrich I; Reichl S; Müller-Goymann CC
Int J Pharm; 2005 Nov; 305(1-2):167-75. PubMed ID: 16242276
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
Ahuja M; Dhake AS; Sharma SK; Majumdar DK
J Microencapsul; 2011; 28(1):37-45. PubMed ID: 21171815
[TBL] [Abstract][Full Text] [Related]
10. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of quercetin nanocrystals: comparison of different methods.
Kakran M; Shegokar R; Sahoo NG; Shaal LA; Li L; Müller RH
Eur J Pharm Biopharm; 2012 Jan; 80(1):113-21. PubMed ID: 21896330
[TBL] [Abstract][Full Text] [Related]
12. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
[TBL] [Abstract][Full Text] [Related]
13. Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18.
Pardeike J; Müller RH
Int J Pharm; 2010 May; 391(1-2):322-9. PubMed ID: 20214969
[TBL] [Abstract][Full Text] [Related]
14. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
[TBL] [Abstract][Full Text] [Related]
15. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
Cao F; Wang Y; Ping Q; Liao Z
Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
[TBL] [Abstract][Full Text] [Related]
16. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W
Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976
[TBL] [Abstract][Full Text] [Related]
18. Preparation of a chemically stable quercetin formulation using nanosuspension technology.
Gao L; Liu G; Wang X; Liu F; Xu Y; Ma J
Int J Pharm; 2011 Feb; 404(1-2):231-7. PubMed ID: 21093559
[TBL] [Abstract][Full Text] [Related]
19. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.
Salazar J; Ghanem A; Müller RH; Möschwitzer JP
Eur J Pharm Biopharm; 2012 May; 81(1):82-90. PubMed ID: 22233547
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.
Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
AAPS PharmSciTech; 2006 Mar; 7(1):E27. PubMed ID: 16584158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
